Body & Wellness Technology

ExoMind™ TMS Therapy in Omaha, NE

A Reset for Your Mind

Personalized treatment plan

Amara MedSpa is expanding what "wellness" means at the clinic — treating the mind with the same care as the skin and body. ExoMind™ is a non-invasive transcranial magnetic stimulation (TMS) platform with FDA-cleared indications for certain patients with major depressive disorder and, as an adjunct, adults with obsessive-compulsive disorder. A clinical evaluation can determine which indication, if any, applies to you.

The treatment, explained

Watch how ExoMind™ works

01

How It Works

ExoMind™ uses BTL's ExoTMS technology — a form of transcranial magnetic stimulation (TMS), a neuromodulation approach that's been studied and used clinically for over two decades. Gentle, precisely targeted magnetic pulses are directed at the region of the brain most closely tied to mood regulation, helping restore healthier patterns of brain activity over a course of sessions.

02Medical indication

FDA Clearance

ExoMind™ is FDA-cleared for specified medical indications in the United States, including major depressive disorder. FDA 510(k) clearance establishes substantial equivalence to an existing legally marketed device; it does not constitute FDA approval of general wellness claims. The expanded indications announced by BTL below are diagnosis- and patient-specific — not a clearance for everyday stress, anxiety on its own, or sleep concerns.

03Expanded indications · October 2026

What the new clearances cover.

BTL has announced additional FDA clearances for its ExoMind™ platform. Each indication is specific to a diagnosis and patient group:

01 / ADULT MDD + ANXIETY SYMPTOMS

Depression with accompanying anxiety

Treatment of depressive episodes and reduction of anxiety symptoms in adults with major depressive disorder (MDD) who have not improved enough with antidepressant medication in the current episode. This is not a separate clearance for anxiety disorders or everyday stress.

02 / ADULT OCD

Obsessive-compulsive disorder

Adjunctive treatment for adults with obsessive-compulsive disorder (OCD), alongside their established mental health care.

03 / AGES 15–21

Adolescent MDD

Adjunctive treatment for patients ages 15–21 with major depressive disorder is available at Amara, subject to a clinical evaluation.

At Amara: Adjunctive ExoMind™ treatment is available for eligible adults with OCD and eligible patients ages 15–21 with major depressive disorder. A qualified provider will confirm diagnosis, treatment history, and precautions before recommending care. Read BTL’s October 1, 2026 clearance announcement
04

What to Expect

You'll sit comfortably in a chair while a specialized headpiece delivers magnetic pulses to the scalp. Many people feel a tapping sensation, and treatment generally requires no sedation or downtime. Session length and the number of visits depend on the clinical indication and your individual treatment plan; your provider will explain the schedule at your consultation.

05

Good candidates for ExoMind™

  • Are an adult with major depressive disorder who has not improved enough with antidepressant medication in the current episode, including when anxiety symptoms occur alongside depression
  • Are an adult with obsessive-compulsive disorder considering an adjunct to their existing care
  • Are ages 15–21 with major depressive disorder and seeking an adjunctive option after a clinical evaluation; patients ages 15–17 must be accompanied by a parent or legal guardian
Your next step

Let’s build a plan around you.

Tell us what you’re hoping to change. We’ll help you choose a thoughtful treatment path.

Call Us (402) 616-8652